Dogwood Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.18

-0.05 (-4.07%)

As of Nov 11, 10:08 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,771.2% upside

Low Target $13.69

Average Target $22.08

High Target $22.84

Current Price $1.18

Current
$1.18

Target
$22.08

$13.69 $22.08 avg $22.84

Scenario Analysis

Bear Case

$13.69

1,060.2%

Low target

Base Case

$22.08

+1,771.2%

Avg target

Bull Case

$22.84

+1,835.6%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$7.04

-83.2% from high

52-Week Low

$0.90

+31.0% from low

Target vs 52W High

$22.08

+213.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%